Association of Race and Ethnicity with Prescriptions for Continuous Glucose Monitoring Systems Among a National Sample of Veterans with Diabetes on Insulin Therapy
Authors' conclusion
Among Veterans with diabetes on insulin therapy, there were significant disparities in prescribing of CGM technology by race and ethnicity, which require further study and intervention.
Study context
- Population
- Adults with T1D or T2D on insulin therapy, U.S. Veterans Health Administration; mean age 68.5 years, 96% male, 96.8% T2D
- Participants
- 368,794 adults
- Exposure
- Continuous glucose monitoring (CGM) prescription by race and ethnicity
- Outcome
- Percentage of patients with ≥1 CGM prescription
- Follow-up
- January 1, 2020, to December 31, 2021
Methodological detailsnational sample, multilevel, multivariable mixed-effects models
- National sample
- Multilevel, multivariable mixed-effects models
Main finding
As reported in the abstract
CGM prescription
Adjusted odds ratio (95% CI)
Black or African Americanvs White
0.62(0.59–0.64)
Hispanic or Latinovs Non-Hispanic
0.79(0.74–0.84)
- Overall prescribed CGM
- 11.2%
Observational data: associations, not effects.
Further findings
- Findings were consistent across subgroups with clinical indications for CGM use
Original publication
Association of Race and Ethnicity with Prescriptions for Continuous Glucose Monitoring Systems Among a National Sample of Veterans with Diabetes on Insulin Therapy. Diabetes Technol Ther. Published 23 August 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →